CIR and CII approved and specialized in innovative medical devices, Cisteo MEDICAL supports you from R&D to mass production of your medical device .
The Research Tax Credit (CIR), defined by the tax code, represents a 30% credit , in particular on research expenses entrusted to an organization approved by the Ministry of Higher Education and Research. It allows you to cover part of your innovation expenses .
As Cisteo MEDICAL is approved, certain services fall within the scope of expenses eligible for the CIR.
During the feasibility stages and in addition to the design stages, our Research and Development department can analyze the behavior of your innovative medical device in real conditions :
This step allows you to:
We adapt our service according to the development phase and regulatory requirements and can achieve, in particular, using additive manufacturing methods:
We carry out, in-house, the mechanical design , electronic and software development of test benches in order to:
Our objective as an industrialist and critical subcontractor: to design a medical device designed to be manufactured .
Before initiating the industrialization phase, going through this step allows you to:
Cisteo's QA/RA service can assist you in ensuring DM traceability and supporting the DHF (Device History File) design file through:
In the case of a device under development, all of these services (including elements linked to regulatory compliance) are eligible for the CIR (Research Tax Credit) or the CII (Innovation Tax Credit).
Our teams support, under contract, start-ups and manufacturers of medical devices in their design, development, approval and manufacturing via its microtechnical and regulatory expertise.